1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6AEAAF990F3CD2CD685256C06006AEE58
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/optimizing-commercial-resources-for-pharmaceutical-launch-success?opendocument
18
19opendocument
203.236.170.171
21
22
23
24/bestp/domrep.nsf
25DB




Products & Services Product Launch Resource Allocation

Optimizing Commercial Resources for Pharmaceutical Launch Success

DB Image

ID: 4294


Features:

Metrics, Graphics


Words: 1,200


Published: Pre-2016


Delivery Format: Online PDF Document


 

License Options:


Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
This document contains 17 pages that identify best practices in optimizing commercial resource support for pharmaceutical product launches. The managerial insights, benchmark metrics and key lessons learned from the exchange will help your team target opportunities for improvement, align resource support and increase launch uptake. Key topics include: factors that determine the size of a product team, timing of product team formation, timing of commercial activities for global and country levels, global product team FTE benchmarks for compounds with varying sales potential, marketing support FTE benchmarks, timing and factors regarding product team size reduction.

Industries Profiled:
Pharmaceutical; Manufacturing; Biotech; Consumer Products; Diagnostic; Medical Device


Companies Profiled:
Abbott Laboratories; Eli Lilly and Company; Bristol-Myers Squibb; Bayer; GlaxoSmithKline; AstraZeneca; Amgen

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.